Detected ·
Infinimmune
$75M—
Infinimmune raised $75M in a Series A to advance next-gen antibody treatments for atopic dermatitis and other inflammatory diseases. The round was co-led by Playground Global and Regeneron Ventures, with participation from RA Capital Management, Goldcrest Capital, Forge Life Science Partners, Godfrey Capital, Wild Tree Ventures, Merck Global Healthcare Innovation Fund, and Pear VC.
- Website
- infinimmune.com
- linkedin.com/company/infinimmune
- Amount
- $75 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-11 20:04:59 UTC
- Signal ID
- 027e26d7-e23c-4247-9636-dd47360cad9c
As the API returns it
{
"id": "027e26d7-e23c-4247-9636-dd47360cad9c",
"created_at": "2026-08-11T20:04:59.490579Z",
"company_name": "Infinimmune",
"company_website_url": "infinimmune.com",
"company_linkedin_url": "https://www.linkedin.com/company/infinimmune",
"event_type": "funding",
"funding_amount": 75000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Infinimmune raised $75M in a Series A to advance next-gen antibody treatments for atopic dermatitis and other inflammatory diseases. The round was co-led by Playground Global and Regeneron Ventures, with participation from RA Capital Management, Goldcrest Capital, Forge Life Science Partners, Godfrey Capital, Wild Tree Ventures, Merck Global Healthcare Innovation Fund, and Pear VC.*"
}